Susquehanna International Group’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-14,213
| Closed | -$264K | – | 13185 |
|
|
2020
Q4 | $208K | Buy |
+14,213
| New | +$188K | ﹤0.01% | 9974 |
|
|
2020
Q2 | – | Sell |
-64,523
| Closed | -$656K | – | 11341 |
|
|
2020
Q1 | $266K | Buy |
+64,523
| New | +$302K | ﹤0.01% | 8203 |
|
|
2019
Q4 | – | Sell |
-24,302
| Closed | -$147K | – | 11059 |
|
|
2019
Q3 | $147K | Buy |
24,302
+4,142
| +21% | +$25.8K | ﹤0.01% | 9338 |
|
|
2019
Q2 | $131K | Buy |
+20,160
| New | +$142K | ﹤0.01% | 9471 |
|
|
2019
Q1 | – | Sell |
-16,049
| Closed | -$78K | – | 10263 |
|
|
2018
Q4 | $78K | Buy |
+16,049
| New | +$83.6K | ﹤0.01% | 8325 |
|
|
2018
Q3 | – | Sell |
-14,862
| Closed | -$95K | – | 10629 |
|
|
2018
Q2 | $95K | Buy |
+14,862
| New | +$98.2K | ﹤0.01% | 9065 |
|
|
2018
Q1 | – | Sell |
-17,729
| Closed | -$74K | – | 10546 |
|
|
2017
Q4 | $74K | Buy |
+17,729
| New | +$107K | ﹤0.01% | 8804 |
|
|
2017
Q3 | – | Sell |
-11,578
| Closed | -$137K | – | 9956 |
|
|
2017
Q2 | $137K | Buy |
+11,578
| New | +$148K | ﹤0.01% | 8534 |
|
|
2017
Q1 | – | Sell |
-59,379
| Closed | -$727K | – | 10398 |
|
|
2016
Q4 | $727K | Buy |
+59,379
| New | +$705K | ﹤0.01% | 6193 |
|
|
2015
Q1 | – | Sell |
-21,801
| Closed | -$297K | – | 10148 |
|
|
2014
Q4 | $297K | Buy |
+21,801
| New | +$244K | ﹤0.01% | 8155 |
|
Susquehanna International Group's GNMK Position: Q1 2021 in Review
Susquehanna International Group sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 14,213 shares — an estimated $264K sold.
Susquehanna International Group first reported a position in GNMK in Q4 2014 and held it in 10 quarters. The position peaked at $727K in Q4 2016. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.
- Susquehanna International Group reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
- Susquehanna International Group sold 14,213 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $264K.
- Susquehanna International Group first reported a position in GenMark Diagnostics, Inc in Q4 2014 and held it in 10 quarters.
- Susquehanna International Group's GenMark Diagnostics, Inc position peaked at $727K in Q4 2016.
- 164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.
Based on Susquehanna International Group's 13F filing for Q1 2021, filed 17 May 2021.